ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MELANIE JEWELL MD

Geriatric Medicine

12,055

$715K

637
545 are 65+

5%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $50

ALAN BERG MD

Geriatric Medicine

12,011

$685K

385
321 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

CLAUDINE CLARKE MD

Geriatric Medicine

11,623

$498K

352
340 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

FAINA CAPLAN MD

Geriatric Medicine

11,440

$544K

328
319 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

DONNA RAZIANO MD MBA

Geriatric Medicine

10,982

$558

275
251 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

RITA REICHARD MD

Geriatric Medicine

10,844

$670K

318
278 are 65+

27%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

ANTONIA CHADWICK MD

Geriatric Medicine

10,331

$737K

395
342 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $50

WILLIAM GIBBONS MD

Geriatric Medicine

10,078

$572K

454
419 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

CHARLES SPENCER MD

Geriatric Medicine

10,072

$281K

299
278 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$28
Average prescription price

Avg: $50

ALFRED STILLMAN MD

Geriatric Medicine

10,014

$418K

339
291 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $50

KARL SCHWABE MD

Geriatric Medicine

9,498

$510K

423
360 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $50

SUPRIYO GHOSH MD

Geriatric Medicine

8,955

$599K

526
471 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

WARD BECKER M.D.

Geriatric Medicine

8,877

$415K

234
230 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

PETER BRIER MD

Geriatric Medicine

8,174

$584K

411
334 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $50

RACHEL SHIPLEY M.D.

Geriatric Medicine

8,070

$413K

490
421 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

ROBERT PFOFF MD

Geriatric Medicine

7,848

$407K

122
109 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

JOSEPH GOLDSCHMIDT MD

Geriatric Medicine

7,818

$417K

340
324 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

QINGPING WANG M.D., PH.D.

Geriatric Medicine

7,637

$345K

179
179 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

IRA SHARP M.D.

Geriatric Medicine

7,439

$406K

383
325 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

GERARD MILLER M.D.

Geriatric Medicine

7,330

$479K

268
252 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

DOROTHY CANDIB MD

Geriatric Medicine

7,265

$360K

235
234 are 65+

42%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

WILLIAM ZIRKER MD

Geriatric Medicine

7,219

$372K

223
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

RUSSELL RENTLER MD

Geriatric Medicine

7,196

$329K

269
258 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

JOEL POSNER MD

Geriatric Medicine

7,055

$438K

407
407 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

SUSAN MOYER MD

Geriatric Medicine

6,899

$459K

513
510 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank